Winfield Associates’s Atrion Corp ATRI Stock Holding History

Winfield Associates’s Portfolio ATRI Stock Details ATRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4	Closed	-$3K	–	908
2017 Q2	$3K	Buy	+4	New	+$2.15K	﹤0.01%	651

Other funds holding ATRI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winfield Associates's ATRI Position: Q3 2017 in Review

Winfield Associates sold out of Atrion Corp (ATRI) in Q3 2017, closing a stake of 4 shares — an estimated $3K sold.

Winfield Associates first reported a position in ATRI in Q2 2017 and held it in 1 quarter. The position peaked at $3K in Q2 2017. 117 funds tracked by Wall St. Rank hold ATRI as of Q3 2017.

Winfield Associates reported no remaining Atrion Corp position as of Q3 2017 after selling out during the quarter.
Winfield Associates sold 4 Atrion Corp shares in Q3 2017, an estimated $3K.
Winfield Associates first reported a position in Atrion Corp in Q2 2017 and held it in 1 quarter.
Winfield Associates's Atrion Corp position peaked at $3K in Q2 2017.
117 funds tracked by Wall St. Rank held Atrion Corp as of Q3 2017.

Based on Winfield Associates's 13F filing for Q3 2017, filed 6 Nov 2017.